Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NIRAPARIB Cause Chronic kidney disease? 29 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Chronic kidney disease have been filed in association with NIRAPARIB (ZEJULA). This represents 0.1% of all adverse event reports for NIRAPARIB.

29
Reports of Chronic kidney disease with NIRAPARIB
0.1%
of all NIRAPARIB reports
2
Deaths
5
Hospitalizations

How Dangerous Is Chronic kidney disease From NIRAPARIB?

Of the 29 reports, 2 (6.9%) resulted in death, 5 (17.2%) required hospitalization, and 2 (6.9%) were considered life-threatening.

Is Chronic kidney disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NIRAPARIB. However, 29 reports have been filed with the FAERS database.

What Other Side Effects Does NIRAPARIB Cause?

Nausea (5,794) Fatigue (5,240) Constipation (4,128) Platelet count decreased (4,102) Insomnia (2,861) Blood pressure increased (2,464) Headache (2,383) Off label use (2,213) Vomiting (2,029) Carbohydrate antigen 125 increased (1,868)

What Other Drugs Cause Chronic kidney disease?

OMEPRAZOLE (35,759) ESOMEPRAZOLE (35,281) LANSOPRAZOLE (32,517) PANTOPRAZOLE (28,127) DEXLANSOPRAZOLE (15,973) EMTRICITABINE\TENOFOVIR DISOPROXIL (10,248) TENOFOVIR DISOPROXIL (7,230) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (5,861) RABEPRAZOLE (4,773) ESOMEPRAZOLE\NAPROXEN (2,714)

Which NIRAPARIB Alternatives Have Lower Chronic kidney disease Risk?

NIRAPARIB vs NIRMATRELVIR\RITONAVIR NIRAPARIB vs NIROGACESTAT NIRAPARIB vs NIROGACESTAT HYDROBROMIDE NIRAPARIB vs NIRSEVIMAB NIRAPARIB vs NIRSEVIMAB-ALIP

Related Pages

NIRAPARIB Full Profile All Chronic kidney disease Reports All Drugs Causing Chronic kidney disease NIRAPARIB Demographics